Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
DraftKings Inc is a gambling business based in the US. DraftKings shares (DKNG) are listed on the NASDAQ and all prices are listed in US Dollars. DraftKings employs 2,600 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$51.75|
|52-week range||$34.90 - $74.38|
|50-day moving average||$55.75|
|200-day moving average||$55.11|
|Wall St. target price||$71.15|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-3.34|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-09-17)||-14.35%|
|1 month (2021-08-24)||-8.36%|
|3 months (2021-06-24)||1.35%|
|6 months (2021-03-24)||-22.33%|
|1 year (2020-09-24)||2.33%|
|2 years (2019-09-24)||425.38%|
|3 years (2018-09-20)||N/A|
|5 years (2016-09-20)||N/A|
|Revenue TTM||$1.1 billion|
|Gross profit TTM||$267.9 million|
|Return on assets TTM||-22.3%|
|Return on equity TTM||-58.69%|
|Market capitalisation||$24.2 billion|
TTM: trailing 12 months
There are currently 33.1 million DraftKings shares held short by investors – that's known as DraftKings's "short interest". This figure is 3.4% up from 32.0 million last month.
There are a few different ways that this level of interest in shorting DraftKings shares can be evaluated.
DraftKings's "short interest ratio" (SIR) is the quantity of DraftKings shares currently shorted divided by the average quantity of DraftKings shares traded daily (recently around 13.2 million). DraftKings's SIR currently stands at 2.5. In other words for every 100,000 DraftKings shares traded daily on the market, roughly 2500 shares are currently held short.
However DraftKings's short interest can also be evaluated against the total number of DraftKings shares, or, against the total number of tradable DraftKings shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case DraftKings's short interest could be expressed as 0.08% of the outstanding shares (for every 100,000 DraftKings shares in existence, roughly 80 shares are currently held short) or 0.0953% of the tradable shares (for every 100,000 tradable DraftKings shares, roughly 95 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against DraftKings.
Find out more about how you can short DraftKings stock.
We're not expecting DraftKings to pay a dividend over the next 12 months.
DraftKings Inc. operates as a digital sports entertainment and gaming company in the United States. It operates through two segments, Business-to-Consumer and Business-to-Business. The company provides users with daily sports, sports betting, and iGaming opportunities. It is also involved in the design, development, and licensing of sports betting and casino gaming platform software for online and retail sportsbook, and casino gaming products. The company distributes its product offerings through various channels, including traditional websites and direct app downloads, as well as direct-to-consumer digital platforms, such as the Apple App store and the Google Play store. DraftKings Inc.
Everything we know about the Enfusion IPO, plus information on how to buy in.
Everything we know about the Intuity Medical IPO, plus information on how to buy in.
Everything we know about the Pyxis Oncology IPO, plus information on how to buy in.
Everything we know about the AEON Biopharma IPO, plus information on how to buy in.
Everything we know about the IHS Holding Ltd IPO, plus information on how to buy in.
Everything we know about the BT Brands IPO, plus information on how to buy in.
Everything we know about the Immix IPO, plus information on how to buy in.
Everything we know about the Keter Group SA IPO, plus information on how to buy in.
Everything we know about the Theseus Pharmaceuticals IPO, plus information on how to buy in.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq on Sep. 20, 2021
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.